Related Experiment Video
Updated: Oct 9, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Mycophenolate mofetil-induced peripheral neuropathy in the treatment of membranous glomerulonephropathy: A case
Minoo Moghimi1, Zahra Nekoukar1, Farhad Gholami2
1Department of Clinical Pharmacy Mazandaran University of Medical Sciences Sari Iran.
Abstract:
Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we described a 66-year-old male MGN case treated with MMF and revealed acquired sensory-motor axonal polyneuropathy, which is rare and has not been reported before.
More Related Videos
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease II: Clinical Manifestations

